| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |